logo-loader
viewIntegumen

Full interview: Integumen PLC well funded as it continues growth towards profitability

Integumen PLC (LON:SKIN) CEO Gerry Brandon talks Proactive London's Andrew Scott through the firm's first half numbers.

Revenues from continuing operations had increased 540% to £346,697, while its EBITDA loss had fallen 32% to £370,102.

That doesn't include RinoCloud revenues of £178,000 from January 2019 - April 2019.

Brandon says the current level of activity in the pipeline's significantly higher than they've seen in the past and demand for its products and services has continued to increase.

Quick facts: Integumen

Price: 1.41 GBX

AIM:SKIN
Market: AIM
Market Cap: £15.12 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen's Gerry Brandon outlines alliance with South Africa’s Acumen Software

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott soon after announcing they've formed an alliance with South Africa’s Acumen Software. Acumen's a specialist supplier to municipal and utility customers and the agreement will see Integumen broaden...

3 weeks, 2 days ago

2 min read